Parthanatos, a messenger of death.

Poly-ADP-ribose polymerase-1 (PARP-1)'s roles in the cell span from maintaining life to inducing death. The processes PARP-1 is involved in include DNA repair, DNA transcription, mitosis, and cell death. Of PARP-1's different cellular functions, its role in cell death is of particular interest to designing therapies for diseases. Genetic deletion of PARP-1 revealed that PARP-1 overactivation underlies cell death in models of stroke, diabetes, inflammation and neurodegeneration. Since interfering with PARP-1 mediated cell death will be clinically beneficial, great effort has been invested into understanding mechanisms downstream of PARP-1 overactivation. Recent evidence shows that poly-ADP ribose (PAR) polymer itself can act as a cell death effector downstream of PARP-1. We coined the term parthanatos after Thanatos, the personification of death in Greek mythology, to refer to PAR-mediated cell death. In this review, we will present evidence and questions raised by these recent findings, and summarize the proposed mechanisms by which PARP-1 overactivation kills. It is evident that further understanding of parthanatos opens up new avenues for therapy in ameliorating diseases related to PARP-1 overactivation.

[1]  S. Snyder,et al.  Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. , 1994, Science.

[2]  M. Hottiger,et al.  Nuclear ADP-Ribosylation Reactions in Mammalian Cells: Where Are We Today and Where Are We Going? , 2006, Microbiology and Molecular Biology Reviews.

[3]  Y. Nishizuka,et al.  Studies on the polymer of adenosine diphosphate ribose. I. Enzymic formation from nicotinamide adenine dinuclotide in mammalian nuclei. , 1967, The Journal of biological chemistry.

[4]  G. Kroemer,et al.  NADH Oxidase Activity of Mitochondrial Apoptosis-inducing Factor* , 2001, The Journal of Biological Chemistry.

[5]  N. Plesnila,et al.  Apoptosis-Inducing Factor Triggered by Poly(ADP-Ribose) Polymerase and Bid Mediates Neuronal Cell Death after Oxygen-Glucose Deprivation and Focal Cerebral Ischemia , 2005, The Journal of Neuroscience.

[6]  P. Vandenabeele,et al.  The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet , 2002, Cell Death and Differentiation.

[7]  T. Dawson,et al.  Poly(ADP-ribose) polymerase-1 and apoptosis inducing factor in neurotoxicity , 2003, Neurobiology of Disease.

[8]  N. Berger Poly(ADP-ribose) in the cellular response to DNA damage. , 1985, Radiation research.

[9]  Dudley Lamming,et al.  Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell Survival , 2007, Cell.

[10]  T. Mak,et al.  Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death , 2001, Nature.

[11]  S. Snyder,et al.  Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Bénit,et al.  AIF deficiency compromises oxidative phosphorylation , 2004, The EMBO journal.

[13]  J. Moss,et al.  Identification and Characterization of a Mammalian 39-kDa Poly(ADP-ribose) Glycohydrolase* , 2006, Journal of Biological Chemistry.

[14]  R. Lang,et al.  Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy. , 2006, American journal of physiology. Heart and circulatory physiology.

[15]  R. Clark,et al.  Critical Role of Calpain I in Mitochondrial Release of Apoptosis-Inducing Factor in Ischemic Neuronal Injury , 2007, The Journal of Neuroscience.

[16]  Zhao-Qi Wang,et al.  Poly(ADP-ribose) Accumulation and Enhancement of Postischemic Brain Damage in 110-kDa Poly(ADP-ribose) Glycohydrolase Null Mice , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  N. Plesnila,et al.  Nuclear Translocation of Apoptosis-Inducing Factor after Focal Cerebral Ischemia , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  S. Snyder,et al.  Nitric oxide as a mediator of neurotoxicity. , 1993, NIDA research monograph.

[19]  D. Guastella,et al.  Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Halestrap,et al.  Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury , 1997 .

[21]  T. Dawson,et al.  Apoptosis Inducing Factor and PARP‐Mediated Injury in the MPTP Mouse Model of Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.

[22]  T. Dawson,et al.  Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[23]  R. Koehler,et al.  Poly(ADP-ribose) (PAR) polymer is a death signal , 2006, Proceedings of the National Academy of Sciences.

[24]  G. Kroemer,et al.  Bcl-2 inhibits the mitochondrial release of an apoptogenic protease , 1996, The Journal of experimental medicine.

[25]  S. Imai,et al.  Poly(ADP-ribose) Polymerase-1-dependent Cardiac Myocyte Cell Death during Heart Failure Is Mediated by NAD+ Depletion and Reduced Sir2α Deacetylase Activity* , 2005, Journal of Biological Chemistry.

[26]  Guido Kroemer,et al.  Apoptosis‐inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis , 2000, FEBS letters.

[27]  P. Chambon,et al.  Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme. , 1963, Biochemical and biophysical research communications.

[28]  C. Szabó,et al.  The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors , 2002, Pharmacological Reviews.

[29]  R. Swanson,et al.  Differences among cell types in NAD+ compartmentalization: A comparison of neurons, astrocytes, and cardiac myocytes , 2007, Journal of neuroscience research.

[30]  Changlian Zhu,et al.  Involvement of apoptosis‐inducing factor in neuronal death after hypoxia‐ischemia in the neonatal rat brain , 2003, Journal of neurochemistry.

[31]  M. Moskowitz,et al.  Mechanisms of Reduced Striatal NMDA Excitotoxicity in Type I Nitric Oxide Synthase Knock-Out Mice , 1997, The Journal of Neuroscience.

[32]  M. Hottiger,et al.  The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. , 2008, Frontiers in bioscience : a journal and virtual library.

[33]  P. Bénit,et al.  Muscle-Specific Loss of Apoptosis-Inducing Factor Leads to Mitochondrial Dysfunction, Skeletal Muscle Atrophy, and Dilated Cardiomyopathy , 2005, Molecular and Cellular Biology.

[34]  N. Plesnila,et al.  Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia-ischemia , 2007, Cell Death and Differentiation.

[35]  V. Dawson,et al.  Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. , 1998, Trends in pharmacological sciences.

[36]  Simon C Watkins,et al.  Intranuclear localization of apoptosis‐inducing factor (AIF) and large scale dna fragmentation after traumatic brain injury in rats and in neuronal cultures exposed to peroxynitrite , 2002, Journal of neurochemistry.

[37]  M. Moskowitz,et al.  Ischemic Brain Injury is Mediated by the Activation of Poly(ADP-Ribose)Polymerase , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  D. Ferriero,et al.  Hsp70 Overexpression Sequesters AIF and Reduces Neonatal Hypoxic/Ischemic Brain Injury , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[39]  V. Schreiber,et al.  Poly(ADP-ribose): novel functions for an old molecule , 2006, Nature Reviews Molecular Cell Biology.

[40]  R. Swanson,et al.  Tricarboxylic Acid Cycle Substrates Prevent PARP-Mediated Death of Neurons and Astrocytes , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[41]  David S. Park,et al.  Dissociating the dual roles of apoptosis‐inducing factor in maintaining mitochondrial structure and apoptosis , 2006, The EMBO journal.

[42]  Y. Nishizuka,et al.  Studies on the polymer of adenosine diphosphate ribose. II. Characterization of the polymer. , 1967, The Journal of biological chemistry.

[43]  G. de Murcia,et al.  Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model? , 2000, Mutation research.

[44]  D. Guastella,et al.  NMDA But Not Non-NMDA Excitotoxicity is Mediated by Poly(ADP-Ribose) Polymerase , 2000, The Journal of Neuroscience.

[45]  C. Cosi,et al.  Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide , 1998, Brain Research.

[46]  T. Dawson,et al.  Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor , 2002, Science.

[47]  C. Sheline,et al.  Free radical-mediated neurotoxicity may be caused by inhibition of mitochondrial dehydrogenases in vitro and in vivo , 2006, Neuroscience.

[48]  S. Korsmeyer,et al.  Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[49]  P. Mecocci,et al.  Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[50]  Yigong Shi,et al.  Mechanisms of AIF-Mediated Apoptotic DNA Degradation in Caenorhabditis elegans , 2002, Science.

[51]  T. Dawson,et al.  Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death , 2006, Proceedings of the National Academy of Sciences.

[52]  S. Snyder,et al.  Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia , 1997, Nature Medicine.

[53]  S. Snyder,et al.  Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[54]  C. Szabó,et al.  Poly(ADP-ribose) polymerase inhibition protect neurons and the white matter and regulates the translocation of apoptosis-inducing factor in stroke. , 2004, International journal of molecular medicine.

[55]  Changlian Zhu,et al.  Nitrosylation precedes caspase‐3 activation and translocation of apoptosis‐inducing factor in neonatal rat cerebral hypoxia‐ischaemia , 2004, Journal of neurochemistry.

[56]  J. Pleschke,et al.  Poly(ADP-ribose) Binds to Specific Domains in DNA Damage Checkpoint Proteins* , 2000, The Journal of Biological Chemistry.

[57]  T. Sugimura,et al.  Polymerization of the adenosine 5'-diphosphate-ribose moiety of nicotinamide-adenine dinucleotide by nuclear enzyme. I. Enzymatic reactions. , 1967, Biochimica et biophysica acta.

[58]  W. Paschen,et al.  Effect of Transient Focal Ischemia of Mouse Brain on Energy State and NAD Levels , 2000, Journal of neurochemistry.

[59]  R. Traystman,et al.  Differential Effect of PARP-2 Deletion on Brain Injury after Focal and Global Cerebral Ischemia , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[60]  K. Mihara,et al.  Export of mitochondrial AIF in response to proapoptotic stimuli depends on processing at the intermembrane space , 2005, The EMBO journal.

[61]  M. Moskowitz,et al.  Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. , 1994, Science.

[62]  P. Chambon,et al.  On the formation of a novel adenylic compound by enzymatic extracts of liver nuclei , 1966 .

[63]  B. Chabot,et al.  A proteomic approach to the identification of heterogeneous nuclear ribonucleoproteins as a new family of poly(ADP-ribose)-binding proteins. , 2003, The Biochemical journal.

[64]  Csaba Szabó,et al.  Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors , 2005, Nature Reviews Drug Discovery.

[65]  P. Chambon,et al.  Functional interaction between PARP‐1 and PARP‐2 in chromosome stability and embryonic development in mouse , 2003, The EMBO journal.

[66]  Ruedi Aebersold,et al.  Molecular characterization of mitochondrial apoptosis-inducing factor , 1999, Nature.

[67]  J S Beckman,et al.  Pathological implications of nitric oxide, superoxide and peroxynitrite formation. , 1993, Biochemical Society transactions.

[68]  F. Althaus,et al.  Noncovalent interactions of poly(adenosine diphosphate ribose) with histones. , 1992, Biochemistry.

[69]  R. Clark,et al.  Translocation of Apoptosis-Inducing Factor in Vulnerable Neurons after Transient Cerebral Ischemia and in Neuronal Cultures after Oxygen-Glucose Deprivation , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[70]  G. Kroemer,et al.  Dominant cell death induction by extramitochondrially targeted apoptosis‐inducing factor , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[71]  M. Altmeyer,et al.  Quantitative analysis of the binding affinity of poly(ADP-ribose) to specific binding proteins as a function of chain length , 2007, Nucleic acids research.

[72]  S. Mori,et al.  Poly(ADP-Ribose) Polymerase Impairs Early and Long-Term Experimental Stroke Recovery , 2002, Stroke.

[73]  C. Brenner,et al.  The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. , 2003, Current medicinal chemistry.

[74]  Tetsuya Watanabe,et al.  Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death , 2005, Nature.

[75]  J. Ménissier-de murcia,et al.  Sequential Activation of Poly(ADP-Ribose) Polymerase 1, Calpains, and Bax Is Essential in Apoptosis-Inducing Factor-Mediated Programmed Necrosis , 2007, Molecular and Cellular Biology.

[76]  S. Hanai,et al.  Loss of poly(ADP-ribose) glycohydrolase causes progressive neurodegeneration in Drosophila melanogaster , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[77]  Ahmed Haouz,et al.  The crystal structure of the mouse apoptosis-inducing factor AIF , 2002, Nature Structural Biology.

[78]  Josef M. Penninger,et al.  Heat-shock protein 70 antagonizes apoptosis-inducing factor , 2001, Nature Cell Biology.

[79]  J. d'Alayer,et al.  Cysteine protease inhibition prevents mitochondrial apoptosis-inducing factor (AIF) release , 2005, Cell Death and Differentiation.

[80]  Lorenzo Galluzzi,et al.  Mitochondrial membrane permeabilization in cell death. , 2007, Physiological reviews.

[81]  D. Nicholls,et al.  Calpain I Induces Cleavage and Release of Apoptosis-inducing Factor from Isolated Mitochondria* , 2005, Journal of Biological Chemistry.

[82]  Jeffrey Robbins,et al.  Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death , 2005, Nature.

[83]  S. Lipton,et al.  Excitatory amino acids as a final common pathway for neurologic disorders. , 1994, The New England journal of medicine.

[84]  A. Iwashita,et al.  Neuroprotective Effects of a Novel Poly(ADP-Ribose) Polymerase-1 Inhibitor, 2-{3-[4-(4-Chlorophenyl)-1-piperazinyl] propyl}-4(3H)-quinazolinone (FR255595), in an in Vitro Model of Cell Death and in Mouse 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Model of Parkinson's Disease , 2004, Journal of Pharmacology and Experimental Therapeutics.

[85]  Wayne N. Frankel,et al.  The harlequin mouse mutation downregulates apoptosis-inducing factor , 2002, Nature.

[86]  G. Poirier,et al.  Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. , 1999, The Biochemical journal.